{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:19:16Z","timestamp":1792664356240,"version":"4.5.0"},"reference-count":122,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T00:00:00Z","timestamp":1539648000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T00:00:00Z","timestamp":1539648000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["EY024710"],"award-info":[{"award-number":["EY024710"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["EY029426"],"award-info":[{"award-number":["EY029426"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s00018-018-2938-1","type":"journal-article","created":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T12:49:15Z","timestamp":1539694155000},"page":"405-419","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":121,"title":["Pathological processes activated by herpes simplex virus-1 (HSV-1) infection in the cornea"],"prefix":"10.1007","volume":"76","author":[{"given":"Lulia","family":"Koujah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul K.","family":"Suryawanshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3039-6953","authenticated-orcid":false,"given":"Deepak","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,16]]},"reference":[{"key":"2938_CR1","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.celrep.2017.06.041","volume":"20","author":"AM Agelidis","year":"2017","unstructured":"Agelidis AM, Hadigal SR, Jaishankar D, Shukla D (2017) Viral activation of heparanase drives pathogenesis of herpes simplex virus-1. Cell Rep 20:439\u2013450","journal-title":"Cell Rep"},{"key":"2938_CR2","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.1182\/blood-2008-02-137711","volume":"112","author":"R Ahmad","year":"2008","unstructured":"Ahmad R, El Bassam S, Cordeiro P, Menezes J (2008) Requirement of TLR2-mediated signaling for the induction of IL-15 gene expression in human monocytic cells by HSV-1. Blood 112:2360\u20132368. https:\/\/doi.org\/10.1182\/blood-2008-02-137711","journal-title":"Blood"},{"key":"2938_CR3","doi-asserted-by":"publisher","first-page":"4026","DOI":"10.1167\/iovs.08-1807","volume":"49","author":"J Akhtar","year":"2008","unstructured":"Akhtar J, Tiwari V, Oh MJ, Kovacs M, Jani A, Kovacs SK, Valyi-Nagy T, Shukla D (2008) HVEM and nectin-1 are the major mediators of herpes simplex virus 1 (HSV-1) entry into human conjunctival epithelium. Invest Ophthalmol Vis Sci 49:4026\u20134035. https:\/\/doi.org\/10.1167\/iovs.08-1807","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2938_CR4","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/nri1391","volume":"4","author":"S Akira","year":"2004","unstructured":"Akira S, Takeda K (2004) Toll-like receptor signalling. Nat Rev Immunol 4:499\u2013511","journal-title":"Nat Rev Immunol"},{"key":"2938_CR5","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/90609","volume":"2","author":"S Akira","year":"2001","unstructured":"Akira S, Takeda K, Kaisho T (2001) Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2:675\u2013680. https:\/\/doi.org\/10.1038\/90609","journal-title":"Nat Immunol"},{"key":"2938_CR6","first-page":"18","volume":"39","author":"S Amano","year":"1998","unstructured":"Amano S, Rohan R, Kuroki M, Tolentino M, Adamis AP (1998) Requirement for vascular endothelial growth factor in wound- and inflammation-related corneal neovascularization. Invest Ophthalmol Vis Sci 39:18\u201322","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2938_CR7","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1084\/jem.20142274","volume":"212","author":"LL Andersen","year":"2015","unstructured":"Andersen LL, Mork N, Reinert LS, Kofod-Olsen E, Narita R, Jorgensen SE, Skipper KA, Honing K, Gad HH, Ostergaard L, Orntoft TF, Hornung V, Paludan SR, Mikkelsen JG, Fujita T, Christiansen M, Hartmann R, Mogensen TH (2015) Functional IRF3 deficiency in a patient with herpes simplex encephalitis. J Exp Med 212:1371\u20131379. https:\/\/doi.org\/10.1084\/jem.20142274","journal-title":"J Exp Med"},{"key":"2938_CR8","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1002\/rmv.1740","volume":"23","author":"T Antoine","year":"2013","unstructured":"Antoine T, Park PJ, Shukla D (2013) Glycoprotein targeted therapeutics: a new era of anti-herpes simplex virus-1 therapeutics. Rev Med Virol 23:194\u2013208. https:\/\/doi.org\/10.1002\/rmv.1740","journal-title":"Rev Med Virol"},{"key":"2938_CR9","first-page":"264","volume":"104","author":"DT Azar","year":"2006","unstructured":"Azar DT (2006) Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an american ophthalmological society thesis). Trans Am Ophthalmol Soc 104:264\u2013302","journal-title":"Trans Am Ophthalmol Soc"},{"key":"2938_CR10","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/7261980","author":"TN Azher","year":"2017","unstructured":"Azher TN, Yin X, Stuart PM (2017) Understanding the role of chemokines and cytokines in experimental models of herpes simplex keratitis. J Immunol Res. https:\/\/doi.org\/10.1155\/2017\/7261980","journal-title":"J Immunol Res"},{"key":"2938_CR11","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nri.2015.4","volume":"16","author":"MC Basil","year":"2015","unstructured":"Basil MC, Levy BD (2015) Specialized pro-resolving mediators: endogenous regulators of infection and inflammation. Nat Rev Immunol 16:51\u201367. https:\/\/doi.org\/10.1038\/nri.2015.4","journal-title":"Nat Rev Immunol"},{"key":"2938_CR12","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.3389\/fmicb.2017.02115","volume":"8","author":"D Bauer","year":"2017","unstructured":"Bauer D, Alt M, Dirks M, Buch A, Heilingloh CS, Dittmer U, Giebel B, G\u00f6rgens A, Palapys V, Kasper M, Eis-H\u00fcbinger AM, Sodeik B, Heiligenhaus A, Roggendorf M, Krawczyk A (2017) A Therapeutic Antiviral Antibody Inhibits the Anterograde Directed Neuron-to-Cell Spread of Herpes Simplex Virus and Protects against Ocular Disease. 8:2115. https:\/\/doi.org\/10.3389\/fmicb.2017.02115","journal-title":"A Therapeutic Antiviral Antibody Inhibits the Anterograde Directed Neuron-to-Cell Spread of Herpes Simplex Virus and Protects against Ocular Disease."},{"key":"2938_CR13","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/35036374","volume":"2","author":"G Bergers","year":"2000","unstructured":"Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki K, Tanzawa K, Thorpe P, Itohara S, Werb Z, Hanahan D (2000) Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2:737\u2013744. https:\/\/doi.org\/10.1038\/35036374","journal-title":"Nat Cell Biol"},{"key":"2938_CR14","doi-asserted-by":"publisher","first-page":"4263","DOI":"10.1167\/iovs.08-2077","volume":"49","author":"PS Bhattacharjee","year":"2008","unstructured":"Bhattacharjee PS, Neumann DM, Foster TP, Clement C, Singh G, Thompson HW, Kaufman HE, Hill JM (2008) Effective treatment of ocular HSK with a human apolipoprotein E mimetic peptide in a mouse eye model. Invest Ophthalmol Vis Sci 49:4263\u20134268. https:\/\/doi.org\/10.1167\/iovs.08-2077","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2938_CR15","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1093\/emboj\/19.7.1525","volume":"19","author":"R Binetruy-Tournaire","year":"2000","unstructured":"Binetruy-Tournaire R, Demangel C, Malavaud B, Vassy R, Rouyre S, Kraemer M, Plouet J, Derbin C, Perret G, Mazie JC (2000) Identification of a peptide blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis. EMBO J 19:1525\u20131533","journal-title":"EMBO J"},{"key":"2938_CR16","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.micinf.2005.03.003","volume":"7","author":"PS Biswas","year":"2005","unstructured":"Biswas PS, Rouse BT (2005) Early events in HSV keratitis\u2014setting the stage for a blinding disease. Microbes Infect 7:799\u2013810. https:\/\/doi.org\/10.1016\/j.micinf.2005.03.003","journal-title":"Microbes Infect"},{"key":"2938_CR17","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.antiviral.2012.09.022","volume":"96","author":"N Boivin","year":"2012","unstructured":"Boivin N, Menasria R, Piret J, Boivin G (2012) Modulation of TLR9 response in a mouse model of herpes simplex virus encephalitis. Antiviral Res 96:414\u2013421. https:\/\/doi.org\/10.1016\/j.antiviral.2012.09.022","journal-title":"Antiviral Res"},{"key":"2938_CR18","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s13311-016-0433-7","volume":"13","author":"MJ Bradshaw","year":"2016","unstructured":"Bradshaw MJ, Venkatesan A (2016) Herpes simplex virus-1 encephalitis in adults: pathophysiology. Diag Manag 13:493\u2013508. https:\/\/doi.org\/10.1007\/s13311-016-0433-7","journal-title":"Diag Manag"},{"key":"2938_CR19","doi-asserted-by":"publisher","first-page":"5118","DOI":"10.1167\/iovs.07-0302","volume":"48","author":"CR Brandt","year":"2007","unstructured":"Brandt CR, Akkarawongsa R, Altmann S, Jose G, Kolb AW, Waring AJ, Lehrer RI (2007) Evaluation of a theta-defensin in a Murine model of herpes simplex virus type 1 keratitis. Invest Ophthalmol Vis Sci 48:5118\u20135124","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2938_CR20","doi-asserted-by":"publisher","first-page":"379","DOI":"10.4049\/jimmunol.1402326","volume":"194","author":"K-G Buela","year":"2015","unstructured":"Buela K-G, Hendricks RL (2015) Cornea-infiltrating and lymph node dendritic cells contribute to CD4\u2009+\u2009T cell expansion after herpes simplex virus-1 ocular infection. J Immunol 194:379\u2013387. https:\/\/doi.org\/10.4049\/jimmunol.1402326","journal-title":"J Immunol"},{"key":"2938_CR21","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S1097-2765(01)00298-2","volume":"8","author":"A Carfi","year":"2001","unstructured":"Carfi A, Willis SH, Whitbeck JC, Krummenacher C, Cohen GH, Eisenberg RJ, Wiley DC (2001) Herpes simplex virus glycoprotein D bound to the human receptor HveA. Mol Cell 8:169\u2013179","journal-title":"Mol Cell"},{"key":"2938_CR22","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/74651","volume":"6","author":"P Carmeliet","year":"2000","unstructured":"Carmeliet P (2000) Mechanisms of angiogenesis and arteriogenesis. Nat Med 6:389\u2013395. https:\/\/doi.org\/10.1038\/74651","journal-title":"Nat Med"},{"key":"2938_CR23","doi-asserted-by":"publisher","first-page":"3984","DOI":"10.1167\/iovs.10-6449","volume":"52","author":"HM Cathcart","year":"2011","unstructured":"Cathcart HM, Zheng M, Covar JJ, Liu Y, Podolsky R, Atherton SS (2011) Interferon-gamma, macrophages, and virus spread after HSV-1 injection. Invest Ophthalmol Vis Sci 52:3984\u20133993. https:\/\/doi.org\/10.1167\/iovs.10-6449","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2938_CR24","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1097\/00055735-200108000-00002","volume":"12","author":"JH Chang","year":"2001","unstructured":"Chang JH, Gabison EE, Kato T, Azar DT (2001) Corneal neovascularization. Curr Opin Ophthalmol 12:242\u2013249","journal-title":"Curr Opin Ophthalmol"},{"key":"2938_CR25","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1111\/j.1346-8138.2011.01441.x","volume":"39","author":"Y Chen","year":"2012","unstructured":"Chen Y, Chen Y, Huang L, Yu J (2012) Evaluation of heparanase and matrix metalloproteinase-9 in patients with cutaneous malignant melanoma. J Dermatol 39:339\u2013343. https:\/\/doi.org\/10.1111\/j.1346-8138.2011.01441.x","journal-title":"J Dermatol"},{"key":"2938_CR26","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1083\/jcb.200509155","volume":"174","author":"C Clement","year":"2006","unstructured":"Clement C, Tiwari V, Scanlan PM, Valyi-Nagy T, Yue BY, Shukla D (2006) A novel role for phagocytosis-like uptake in herpes simplex virus entry. J Cell Biol 174:1009\u20131021","journal-title":"J Cell Biol"},{"key":"2938_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jneuroim.2009.09.013","volume":"220","author":"CD Conrady","year":"2010","unstructured":"Conrady CD, Drevets DA, Carr DJJ (2010) Herpes simplex type I (HSV-1) infection of the nervous system: is an immune response a good thing? J Neuroimmunol 220:1\u20139. https:\/\/doi.org\/10.1016\/j.jneuroim.2009.09.013","journal-title":"J Neuroimmunol"},{"key":"2938_CR28","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1172\/JCI20465","volume":"113","author":"C Cursiefen","year":"2004","unstructured":"Cursiefen C, Chen L, Borges LP, Jackson D, Cao J, Radziejewski C, D\u2019Amore PA, Dana MR, Wiegand SJ, Streilein JW (2004) VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J Clin Invest 113:1040\u20131050. https:\/\/doi.org\/10.1172\/JCI20465","journal-title":"J Clin Invest"},{"key":"2938_CR29","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0014-5793(98)01086-2","volume":"436","author":"I Delrieu","year":"1998","unstructured":"Delrieu I, Arnaud E, Ferjoux G, Bayard F, Faye JC (1998) Overexpression of the FGF-2 24-kDa isoform up-regulates IL-6 transcription in NIH-3T3 cells. FEBS Lett 436:17\u201322. https:\/\/doi.org\/10.1016\/S0014-5793(98)01086-2","journal-title":"FEBS Lett"},{"key":"2938_CR30","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/S1097-2765(00)80221-X","volume":"4","author":"BP Eliceiri","year":"1999","unstructured":"Eliceiri BP, Paul R, Schwartzberg PL, Hood JD, Leng J, Cheresh DA (1999) Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability. Mol Cell 4:915\u2013924","journal-title":"Mol Cell"},{"key":"2938_CR31","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/0002-9343(82)90055-9","volume":"73","author":"GB Elion","year":"1982","unstructured":"Elion GB (1982) Mechanism of action and selectivity of acyclovir. Am J Med 73:7\u201313. https:\/\/doi.org\/10.1016\/0002-9343(82)90055-9","journal-title":"Am J Med"},{"key":"2938_CR32","doi-asserted-by":"publisher","first-page":"416","DOI":"10.7326\/0003-4819-76-3-112-6-416","volume":"112","author":"JA Englund","year":"1990","unstructured":"Englund JA, Zimmerman ME, Swierkosz EM, Goodman JL, Scholl DR, Balfour HH Jr (1990) Herpes simplex virus resistant to acyclovir. A study in a tertiary care center. Ann Intern Med 112:416\u2013422","journal-title":"Ann Intern Med"},{"key":"2938_CR33","doi-asserted-by":"publisher","first-page":"445","DOI":"10.3109\/02713681003734841","volume":"35","author":"AV Farooq","year":"2010","unstructured":"Farooq AV, Valyi-Nagy T, Shukla D (2010) Mediators and mechanisms of herpes simplex virus entry into ocular cells. Curr Eye Res 35:445\u2013450. https:\/\/doi.org\/10.3109\/02713681003734841","journal-title":"Curr Eye Res"},{"key":"2938_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/CMR.7.1.1","volume":"7","author":"AK Field","year":"1994","unstructured":"Field AK, Biron KK (1994) \u201cThe end of innocence\u201d revisited: resistance of herpesviruses to antiviral drugs. Clin Microbiol Rev 7:1\u201313","journal-title":"Clin Microbiol Rev"},{"key":"2938_CR35","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.4049\/jimmunol.1101968","volume":"188","author":"GM Frank","year":"2012","unstructured":"Frank GM, Buela K-G, Maker DM, Harvey SAK, Hendricks RL (2012) Early responding dendritic cells direct the local NK response to control herpes simplex virus 1 infection within the cornea. J Immunol 188:1350\u20131359. https:\/\/doi.org\/10.4049\/jimmunol.1101968","journal-title":"J Immunol"},{"key":"2938_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/s1877-1173(10)93009-3","author":"MM Fuster","year":"2010","unstructured":"Fuster MM, Wang L (2010) Endothelial heparan sulfate in angiogenesis. Prog Mol Biol Transl Sci. https:\/\/doi.org\/10.1016\/s1877-1173(10)93009-3","journal-title":"Prog Mol Biol Transl Sci"},{"key":"2938_CR37","first-page":"453","volume":"41","author":"S Gangappa","year":"2000","unstructured":"Gangappa S, Deshpande SP, Rouse BT (2000) Bystander activation of CD4\u2009+\u2009T cells accounts for herpetic ocular lesions. Invest Ophthalmol Vis Sci 41:453\u2013459","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2938_CR38","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1089\/jop.2005.21.114","volume":"21","author":"BM Gebhardt","year":"2005","unstructured":"Gebhardt BM, Varnell ED, Kaufman HE (2005) Inhibition of cyclooxygenase 2 synthesis suppresses Herpes simplex virus type 1 reactivation. J Ocul Pharmacol Ther 21:114\u2013120. https:\/\/doi.org\/10.1089\/jop.2005.21.114","journal-title":"J Ocul Pharmacol Ther"},{"key":"2938_CR39","doi-asserted-by":"publisher","first-page":"e0141925","DOI":"10.1371\/journal.pone.0141925","volume":"10","author":"F Gimenez","year":"2015","unstructured":"Gimenez F, Mulik S, Veiga-Parga T, Bhela S, Rouse BT (2015) Robo 4 counteracts angiogenesis in herpetic stromal keratitis. Plos One 10:e0141925. https:\/\/doi.org\/10.1371\/journal.pone.0141925","journal-title":"Plos One"},{"key":"2938_CR40","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1126\/science.270.5239.1189","volume":"270","author":"TS Griffith","year":"1995","unstructured":"Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA (1995) Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270:1189\u20131192","journal-title":"Science"},{"key":"2938_CR41","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1084\/jem.20101568","volume":"208","author":"Y Guo","year":"2011","unstructured":"Guo Y, Audry M, Ciancanelli M, Alsina L, Azevedo J, Herman M, Anguiano E, Sancho-Shimizu V, Lorenzo L, Pauwels E, Philippe PB, Perez de Diego R, Cardon A, Vogt G, Picard C, Andrianirina ZZ, Rozenberg F, Lebon P, Plancoulaine S, Tardieu M, Valerie D, Jouanguy E, Chaussabel D, Geissmann F, Abel L, Casanova JL, Zhang SY (2011) Herpes simplex virus encephalitis in a patient with complete TLR3 deficiency: TLR3 is otherwise redundant in protective immunity. J Exp Med 208:2083\u20132098. https:\/\/doi.org\/10.1084\/jem.20101568","journal-title":"J Exp Med"},{"key":"2938_CR42","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/mi.2017.26","volume":"11","author":"HR Gurung","year":"2018","unstructured":"Gurung HR, Carr MM, Bryant K, Chucair-Elliott AJ, Carr DJJ (2018) Fibroblast growth factor-2 drives and maintains progressive corneal neovascularization following HSV-1 infection. Mucosal Immunol 11:172\u2013185. https:\/\/doi.org\/10.1038\/mi.2017.26","journal-title":"Mucosal Immunol"},{"key":"2938_CR43","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1084\/jem.192.4.595","volume":"192","author":"H Hacker","year":"2000","unstructured":"Hacker H, Vabulas RM, Takeuchi O, Hoshino K, Akira S, Wagner H (2000) Immune cell activation by bacterial CpG-DNA through myeloid differentiation marker 88 and tumor necrosis factor receptor-associated factor (TRAF)6. J Exp Med 192:595\u2013600. https:\/\/doi.org\/10.1084\/jem.192.4.595","journal-title":"J Exp Med"},{"key":"2938_CR44","doi-asserted-by":"publisher","first-page":"6985","DOI":"10.1038\/ncomms7985","volume":"6","author":"SR Hadigal","year":"2015","unstructured":"Hadigal SR, Agelidis AM, Karasneh GA, Antoine TE, Yakoub AM, Ramani VC, Djalilian AR, Sanderson RD, Shukla D (2015) Heparanase is a host enzyme required for herpes simplex virus-1 release from cells. Nat Commun 6:6985. https:\/\/doi.org\/10.1038\/ncomms7985","journal-title":"Nat Commun"},{"key":"2938_CR45","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.exer.2006.08.001","volume":"84","author":"JM Hill","year":"2007","unstructured":"Hill JM, Bhattacharjee PS, Neumann DM (2007) Apolipoprotein E alleles can contribute to the pathogenesis of numerous clinical conditions including HSV-1 corneal disease. Exp Eye Res 84:801\u2013811","journal-title":"Exp Eye Res"},{"key":"2938_CR46","doi-asserted-by":"publisher","first-page":"11416","DOI":"10.1073\/pnas.0403555101","volume":"101","author":"H Hochrein","year":"2004","unstructured":"Hochrein H, Schlatter B, O\u2019Keeffe M, Wagner C, Schmitz F, Schiemann M, Bauer S, Suter M, Wagner H (2004) Herpes simplex virus type-1 induces IFN-a production via Toll-like receptor 9-dependent and -independent pathways. Proc Natl Acad Sci U S A 101:11416\u201311421. https:\/\/doi.org\/10.1073\/pnas.0403555101","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2938_CR47","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1172\/JCI6889","volume":"103","author":"JM Isner","year":"1999","unstructured":"Isner JM, Asahara T (1999) Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization. J Clin Invest 103:1231\u20131236","journal-title":"J Clin Invest"},{"key":"2938_CR48","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1167\/iovs.15-18365","volume":"57","author":"D Jaishankar","year":"2016","unstructured":"Jaishankar D, Buhrman JS, Valyi-Nagy T, Gemeinhart RA, Shukla D (2016) Extended release of an anti-heparan sulfate peptide from a contact lens suppresses corneal herpes simplex virus-1 infection. Invest Ophthalmol Vis Sci 57:169\u2013180. https:\/\/doi.org\/10.1167\/iovs.15-18365","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2938_CR49","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aan5861","author":"D Jaishankar","year":"2018","unstructured":"Jaishankar D, Yakoub AM, Yadavalli T, Agelidis A, Thakkar N, Hadigal S, Ames J, Shukla D (2018) An off-target effect of BX795 blocks herpes simplex virus type 1 infection of the eye. Sci Transl Med. https:\/\/doi.org\/10.1126\/scitranslmed.aan5861","journal-title":"Sci Transl Med"},{"issue":"Pt 5","key":"2938_CR50","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/eye.1997.193","volume":"11","author":"DG Jayamanne","year":"1997","unstructured":"Jayamanne DG, Vize C, Ellerton CR, Morgan SJ, Gillie RF (1997) Severe reversible ocular anterior segment ischaemia following topical trifluorothymidine (F3T) treatment for herpes simplex keratouveitis. Eye (Lond) 11(Pt 5):757\u2013759. https:\/\/doi.org\/10.1038\/eye.1997.193","journal-title":"Eye (Lond)"},{"key":"2938_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ijos.2016.3","volume":"8","author":"YC Jiang","year":"2016","unstructured":"Jiang YC, Feng H, Lin YC, Guo XR (2016) New strategies against drug resistance to herpes simplex virus. Int J Oral Sci 8:1\u20136. https:\/\/doi.org\/10.1038\/ijos.2016.3","journal-title":"Int J Oral Sci"},{"key":"2938_CR52","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1089\/jop.2007.0084","volume":"24","author":"HE Kaufman","year":"2008","unstructured":"Kaufman HE, Varnell ED, Gebhardt BM, Thompson HW, Atwal E, Rubsamen-Waigmann H, Kleymann G (2008) Efficacy of a helicase-primase inhibitor in animal models of ocular herpes simplex virus type 1 infection. J Ocul Pharmacol Ther 24:34\u201342. https:\/\/doi.org\/10.1089\/jop.2007.0084","journal-title":"J Ocul Pharmacol Ther"},{"key":"2938_CR53","doi-asserted-by":"publisher","first-page":"6760","DOI":"10.1073\/pnas.1220019110","volume":"110","author":"A Krawczyk","year":"2013","unstructured":"Krawczyk A, Arndt MAE, Grosse-Hovest L, Weichert W, Giebel B, Dittmer U, Hengel H, J\u00e4ger D, Schneweis KE, Eis-H\u00fcbinger AM, Roggendorf M, Krauss J (2013) Overcoming drug-resistant herpes simplex virus (HSV) infection by a humanized antibody. Proc Natl Acad Sci USA 110:6760","journal-title":"Proc Natl Acad Sci USA"},{"key":"2938_CR54","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/nrd.2015.2","volume":"15","author":"J Kreuger","year":"2016","unstructured":"Kreuger J, Phillipson M (2016) Targeting vascular and leukocyte communication in angiogenesis, inflammation and fibrosis. Nat Rev Drug Discov 15:125\u2013142. https:\/\/doi.org\/10.1038\/nrd.2015.2","journal-title":"Nat Rev Drug Discov"},{"key":"2938_CR55","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1182\/blood-2003-08-2674","volume":"103","author":"A Krug","year":"2004","unstructured":"Krug A, Luker GD, Barchet W, Leib DA, Akira S, Colonna M (2004) Herpes simplex virus type 1 activates murine natural interferon-producing cells through toll-like receptor 9. Nat Commun 103:1433\u20131437. https:\/\/doi.org\/10.1182\/blood-2003-08-2674","journal-title":"Nat Commun"},{"key":"2938_CR56","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1073\/pnas.0308057100","volume":"101","author":"EA Kurt-Jones","year":"2004","unstructured":"Kurt-Jones EA, Chan M, Zhou S, Wang J, Reed G, Bronson R, Arnold MM, Knipe DM, Finberg RW (2004) Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis. Proc Natl Acad Sci USA 101:1315\u20131320. https:\/\/doi.org\/10.1073\/pnas.0308057100","journal-title":"Proc Natl Acad Sci USA"},{"key":"2938_CR57","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1006\/exer.1999.0790","volume":"70","author":"A Kvanta","year":"2000","unstructured":"Kvanta A, Sarman S, Fagerholm P, Seregard S, Steen B (2000) Expression of matrix metalloproteinase-2 (MMP-2) and vascular endothelial growth factor (VEGF) in inflammation-associated corneal neovascularization. Exp Eye Res 70:419\u2013428. https:\/\/doi.org\/10.1006\/exer.1999.0790","journal-title":"Exp Eye Res"},{"key":"2938_CR58","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1172\/JCI200215755","volume":"110","author":"S Lee","year":"2002","unstructured":"Lee S, Zheng M, Kim B, Rouse BT (2002) Role of matrix metalloproteinase-9 in angiogenesis caused by ocular infection with herpes simplex virus. J Clin Invest 110:1105\u20131111. https:\/\/doi.org\/10.1172\/JCI200215755","journal-title":"J Clin Invest"},{"key":"2938_CR59","first-page":"1649","volume":"18","author":"X Liang","year":"2012","unstructured":"Liang X, Yuan L, Hu J, Yu H, Li T, Lin S, Tang S (2012) Phosphomannopentaose sulfate (PI-88) suppresses angiogenesis by downregulating heparanase and vascular endothelial growth factor in an oxygen-induced retinal neovascularization animal model. Mol Vis 18:1649\u20131657","journal-title":"Mol Vis"},{"key":"2938_CR60","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1038\/nm.2051","volume":"15","author":"Y Liang","year":"2009","unstructured":"Liang Y, Vogel JL, Narayanan A, Peng H, Kristie TM (2009) Inhibition of the histone demethylase LSD1 blocks alpha-herpesvirus lytic replication and reactivation from latency. Nat Med 15:1312\u20131317. https:\/\/doi.org\/10.1038\/nm.2051","journal-title":"Nat Med"},{"key":"2938_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00003226-200101000-00001","volume":"20","author":"TJ Liesegang","year":"2001","unstructured":"Liesegang TJ (2001) Herpes simplex virus epidemiology and ocular importance. Cornea 20:1\u201313. https:\/\/doi.org\/10.1097\/00003226-200101000-00001","journal-title":"Cornea"},{"key":"2938_CR62","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1016\/S0006-291X(02)00350-9","volume":"293","author":"J Liu","year":"2002","unstructured":"Liu J, Crepin M, Liu J-, Barritault D, Ledoux D (2002) FGF-2 and TPA induce matrix metalloproteinase-9 secretion in MCF-7 cells through PKC activation of the Ras\/ERK pathway. Biochem Biophys Res Commun 293:1174\u20131182. https:\/\/doi.org\/10.1016\/S0006-291X(02)00350-9","journal-title":"Biochem Biophys Res Commun"},{"key":"2938_CR63","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1084\/jem.191.9.1459","volume":"191","author":"T Liu","year":"2000","unstructured":"Liu T, Khanna KM, Chen X, Fink DJ, Hendricks RL (2000) Cd8(+) T cells can block herpes simplex virus Type 1 (HSV-1) reactivation from latency in sensory neurons. J Exp Med 191:1459\u20131466","journal-title":"J Exp Med"},{"key":"2938_CR64","doi-asserted-by":"publisher","first-page":"11335","DOI":"10.1073\/pnas.0801617105","volume":"105","author":"X Liu","year":"2008","unstructured":"Liu X, Fitzgerald K, Kurt-Jones E, Finberg R, Knipe DM (2008) Herpesvirus tegument protein activates NF-\u03baB signaling through the TRAF6 adaptor protein. Proc Natl Acad Sci USA 105:11335\u201311339. https:\/\/doi.org\/10.1073\/pnas.0801617105","journal-title":"Proc Natl Acad Sci USA"},{"key":"2938_CR65","doi-asserted-by":"publisher","first-page":"7078","DOI":"10.1128\/JVI.00619-08","volume":"82","author":"P Lundberg","year":"2008","unstructured":"Lundberg P, Ramakrishna C, Brown J, Tyszka JM, Hamamura M, Hinton DR, Kovats S, Nalcioglu O, Weinberg K, Openshaw H, Cantin EM (2008) The immune response to herpes simplex virus type 1 infection in susceptible mice is a major cause of central nervous system pathology resulting in fatal encephalitis. J Virol 82:7078\u20137088. https:\/\/doi.org\/10.1128\/JVI.00619-08","journal-title":"J Virol"},{"key":"2938_CR66","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.ophtha.2011.01.041","volume":"118","author":"S Maddula","year":"2011","unstructured":"Maddula S, Davis DK, Maddula S, Burrow MK, Ambati BK (2011) Horizons in therapy for corneal. Angiogenesis 118:591\u2013599. https:\/\/doi.org\/10.1016\/j.ophtha.2011.01.041","journal-title":"Angiogenesis"},{"key":"2938_CR67","doi-asserted-by":"crossref","first-page":"9166","DOI":"10.1128\/JVI.72.11.9166-9172.1998","volume":"72","author":"DJ Maggs","year":"1998","unstructured":"Maggs DJ, Chang E, Nasisse MP, Mitchell WJ (1998) Persistence of herpes simplex virus type 1 DNA in chronic conjunctival and eyelid lesions of mice. J Virol 72:9166\u20139172","journal-title":"J Virol"},{"key":"2938_CR68","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1016\/S0002-9440(10)62359-0","volume":"166","author":"DS Mansur","year":"2005","unstructured":"Mansur DS, Kroon EG, Nogueira ML, Arantes RME, Rodrigues SCO, Akira S, Gazzinelli RT, Campos MA (2005) Lethal encephalitis in myeloid differentiation factor 88-deficient mice infected with herpes simplex virus 1. Am J Pathol 166:1419\u20131426","journal-title":"Am J Pathol"},{"key":"2938_CR69","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1074\/jbc.M111.279836","volume":"287","author":"V Masola","year":"2012","unstructured":"Masola V, Gambaro G, Tibaldi E, Brunati AM, Gastaldello A, D\u2019Angelo A, Onisto M, Lupo A (2012) Heparanase and syndecan-1 interplay orchestrates fibroblast growth factor-2-induced epithelial-mesenchymal transition in renal tubular cells. J Biol Chem 287:1478\u20131488. https:\/\/doi.org\/10.1074\/jbc.M111.279836","journal-title":"J Biol Chem"},{"key":"2938_CR70","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/BF02307009","volume":"220","author":"PC Maudgal","year":"1983","unstructured":"Maudgal PC, Van Damme B, Missotten L (1983) Corneal epithelial dysplasia after trifluridine use. Graefes Arch Clin Exp Ophthalmol 220:6\u201312","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2938_CR71","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1126\/science.1068883","volume":"296","author":"R Medzhitov","year":"2002","unstructured":"Medzhitov R, Janeway CA Jr (2002) Decoding the patterns of self and nonself by the innate immune system. Science 296:298\u2013300. https:\/\/doi.org\/10.1126\/science.1068883","journal-title":"Science"},{"key":"2938_CR72","doi-asserted-by":"publisher","first-page":"9685","DOI":"10.1128\/JVI.00706-10","volume":"84","author":"VD Menachery","year":"2010","unstructured":"Menachery VD, Pasieka TJ, Leib DA (2010) Interferon regulatory factor 3-dependent pathways are critical for control of herpes simplex virus type 1 central nervous system infection. J Virol 84:9685\u20139694. https:\/\/doi.org\/10.1128\/JVI.00706-10","journal-title":"J Virol"},{"key":"2938_CR73","doi-asserted-by":"publisher","first-page":"409","DOI":"10.2147\/TCRM.S1664","volume":"4","author":"S Modi","year":"2008","unstructured":"Modi S, Van L, Gewirtzman A, Mendoza N, Bartlett B, Tremaine AM, Tyring S (2008) Single-day treatment for orolabial and genital herpes: a brief review of pathogenesis and pharmacology. Ther Clin Risk Manag 4:409\u2013417","journal-title":"Ther Clin Risk Manag"},{"key":"2938_CR74","doi-asserted-by":"publisher","first-page":"793","DOI":"10.4049\/jimmunol.1102251","volume":"188","author":"JE Morris","year":"2012","unstructured":"Morris JE, Zobell S, Yin XT, Zakeri H, Summers BC, Leib DA, Stuart PM (2012) Mice with mutations in Fas and Fas ligand demonstrate increased herpetic stromal keratitis following corneal infection with HSV-1. J Immunol 188:793\u2013799. https:\/\/doi.org\/10.4049\/jimmunol.1102251","journal-title":"J Immunol"},{"key":"2938_CR75","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.ajpath.2012.04.014","volume":"181","author":"S Mulik","year":"2012","unstructured":"Mulik S, Xu J, Reddy PBJ, Rajasagi NK, Gimenez F, Sharma S, Lu PY, Rouse BT (2012) Role of miR-132 in angiogenesis after ocular infection with herpes simplex virus. Am J Pathol 181:525\u2013534. https:\/\/doi.org\/10.1016\/j.ajpath.2012.04.014","journal-title":"Am J Pathol"},{"key":"2938_CR76","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.bbrc.2009.11.027","volume":"391","author":"MJ Oh","year":"2010","unstructured":"Oh MJ, Akhtar J, Desai P, Shukla D (2010) A role for heparan sulfate in viral surfing. Biochem Biophys Res Commun 391:176\u2013181. https:\/\/doi.org\/10.1016\/j.bbrc.2009.11.027","journal-title":"Biochem Biophys Res Commun"},{"key":"2938_CR77","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/nri2937","volume":"11","author":"SR Paludan","year":"2011","unstructured":"Paludan SR, Bowie AG, Horan KA, Fitzgerald KA (2011) Recognition of herpesviruses by the innate immune system. Nat Rev Immunol 11:143\u2013154. https:\/\/doi.org\/10.1038\/nri2937","journal-title":"Nat Rev Immunol"},{"key":"2938_CR78","doi-asserted-by":"publisher","first-page":"6373","DOI":"10.1167\/iovs.13-12832","volume":"54","author":"PJ Park","year":"2013","unstructured":"Park PJ, Antoine TE, Farooq AV, Valyi-Nagy T, Shukla D (2013) An investigative peptide-acyclovir combination to control herpes simplex virus type 1 ocular infection. Invest Ophthalmol Vis Sci 54:6373\u20136381. https:\/\/doi.org\/10.1167\/iovs.13-12832","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2938_CR79","doi-asserted-by":"publisher","first-page":"262415","DOI":"10.1155\/2010\/262415","volume":"2010","author":"GC Perng","year":"2010","unstructured":"Perng GC, Jones C (2010) Towards an understanding of the herpes simplex virus type 1 latency-reactivation cycle. Interdiscip Perspect Infect Dis 2010:262415. https:\/\/doi.org\/10.1155\/2010\/262415","journal-title":"Interdiscip Perspect Infect Dis"},{"key":"2938_CR80","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0166-3542(98)00048-5","volume":"40","author":"LE Pope","year":"1998","unstructured":"Pope LE, Marcelletti JF, Katz LR, Lin JY, Katz DH, Parish ML, Spear PG (1998) The anti-herpes simplex virus activity of n-docosanol includes inhibition of the viral entry process. Antiviral Res 40:85\u201394","journal-title":"Antiviral Res"},{"key":"2938_CR81","doi-asserted-by":"publisher","first-page":"32628","DOI":"10.1074\/jbc.M806266200","volume":"283","author":"A Purushothaman","year":"2008","unstructured":"Purushothaman A, Chen L, Yang Y, Sanderson RD (2008) Heparanase stimulation of protease expression implicates it as a master regulator of the aggressive tumor phenotype in myeloma. J Biol Chem 283:32628\u201332636. https:\/\/doi.org\/10.1074\/jbc.M806266200","journal-title":"J Biol Chem"},{"key":"2938_CR82","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1189\/jlb.3HI1216-511RR","volume":"102","author":"NK Rajasagi","year":"2017","unstructured":"Rajasagi NK, Bhela S, Varanasi SK, Rouse BT (2017) Frontline Science: aspirin-triggered resolvin D1 controls herpes simplex virus-induced corneal immunopathology. J Leukoc Biol 102:1159\u20131171. https:\/\/doi.org\/10.1189\/jlb.3HI1216-511RR","journal-title":"J Leukoc Biol"},{"key":"2938_CR83","doi-asserted-by":"publisher","first-page":"6269","DOI":"10.1167\/iovs.13-12152","volume":"54","author":"NK Rajasagi","year":"2013","unstructured":"Rajasagi NK, Reddy PB, Mulik S, Gjorstrup P, Rouse BT (2013) Neuroprotectin D1 reduces the severity of herpes simplex virus-induced corneal immunopathology. Invest Ophthalmol Vis Sci 54:6269\u20136279. https:\/\/doi.org\/10.1167\/iovs.13-12152","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2938_CR84","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.4049\/jimmunol.1003456","volume":"186","author":"NK Rajasagi","year":"2011","unstructured":"Rajasagi NK, Reddy PB, Suryawanshi A, Mulik S, Gjorstrup P, Rouse BT (2011) Controlling herpes simplex virus-induced ocular inflammatory lesions with the lipid-derived mediator resolvin E1. J Immunol 186:1735\u20131746. https:\/\/doi.org\/10.4049\/jimmunol.1003456","journal-title":"J Immunol"},{"key":"2938_CR85","doi-asserted-by":"publisher","first-page":"4631","DOI":"10.4049\/jimmunol.1103063","volume":"188","author":"NK Rajasagi","year":"2012","unstructured":"Rajasagi NK, Suryawanshi A, Sehrawat S, Reddy PB, Mulik S, Hirashima M, Rouse BT (2012) Galectin-1 reduces the severity of herpes simplex virus-induced ocular immunopathological lesions. J Immunol 188:4631\u20134643. https:\/\/doi.org\/10.4049\/jimmunol.1103063","journal-title":"J Immunol"},{"key":"2938_CR86","doi-asserted-by":"publisher","first-page":"6490","DOI":"10.1074\/jbc.M110.183277","volume":"286","author":"VC Ramani","year":"2011","unstructured":"Ramani VC, Yang Y, Ren Y, Nan L, Sanderson RD (2011) Heparanase plays a dual role in driving hepatocyte growth factor (HGF) signaling by enhancing HGF expression and activity. J Biol Chem 286:6490\u20136499. https:\/\/doi.org\/10.1074\/jbc.M110.183277","journal-title":"J Biol Chem"},{"key":"2938_CR87","doi-asserted-by":"publisher","first-page":"6377","DOI":"10.1167\/iovs.15-16588","volume":"56","author":"M Rogge","year":"2015","unstructured":"Rogge M, Yin X, Godfrey L, Lakireddy P, Potter CA, Del Rosso CR, Stuart PM (2015) Therapeutic use of soluble fas ligand ameliorates acute and recurrent herpetic stromal keratitis in mice. Invest Ophthalmol Vis Sci 56:6377\u20136386. https:\/\/doi.org\/10.1167\/iovs.15-16588","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2938_CR88","first-page":"2503","volume":"1","author":"B Roizman","year":"2007","unstructured":"Roizman B, Knipe DM, Whitley RJ (2007) Herpes simplex viruses. Clin Infect Dis 1:2503\u20132602","journal-title":"Clin Infect Dis"},{"key":"2938_CR89","doi-asserted-by":"publisher","first-page":"11128","DOI":"10.1128\/JVI.01008-07","volume":"81","author":"PP Sarangi","year":"2007","unstructured":"Sarangi PP, Kim B, Kurt-Jones E, Rouse BT (2007) Innate recognition network driving herpes simplex virus-induced corneal immunopathology: role of the toll pathway in early inflammatory events in stromal keratitis. J Virol 81:11128\u201311138. https:\/\/doi.org\/10.1128\/JVI.01008-07","journal-title":"J Virol"},{"key":"2938_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2014.06.015","author":"MM Sauter","year":"2014","unstructured":"Sauter MM, Gauger JJL, Brandt CR (2014) Oligonucleotides designed to inhibit TLR9 block herpes simplex virus type 1 infection at multiple steps. Antiviral Res. https:\/\/doi.org\/10.1016\/j.antiviral.2014.06.015","journal-title":"Antiviral Res"},{"key":"2938_CR91","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1172\/JCI33361","volume":"118","author":"L Scheppke","year":"2008","unstructured":"Scheppke L, Aguilar E, Gariano RF, Jacobson R, Hood J, Doukas J, Cao J, Noronha G, Yee S, Weis S, Martin MB, Soll R, Cheresh DA, Friedlander M (2008) Retinal vascular permeability suppression by topical application of a novel VEGFR2\/Src kinase inhibitor in mice and rabbits. J Clin Invest 118:2337\u20132346. https:\/\/doi.org\/10.1172\/JCI33361","journal-title":"J Clin Invest"},{"key":"2938_CR92","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1083\/jcb.141.7.1659","volume":"141","author":"G Seghezzi","year":"1998","unstructured":"Seghezzi G, Patel S, Ren CJ, Gualandris A, Pintucci G, Robbins ES, Shapiro RL, Galloway AC, Rifkin DB, Mignatti P (1998) Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: an autocrine mechanism contributing to angiogenesis. J Cell Biol 141:1659\u20131673. https:\/\/doi.org\/10.1083\/jcb.141.7.1659","journal-title":"J Cell Biol"},{"key":"2938_CR93","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/nature13479","volume":"510","author":"CN Serhan","year":"2014","unstructured":"Serhan CN (2014) Novel pro-resolving lipid mediators in inflammation are leads for resolution physiology. Nature 510:92\u2013101. https:\/\/doi.org\/10.1038\/nature13479","journal-title":"Nature"},{"key":"2938_CR94","doi-asserted-by":"publisher","first-page":"5995","DOI":"10.1128\/JVI.00034-11","volume":"85","author":"S Sharma","year":"2011","unstructured":"Sharma S, Mulik S, Kumar N, Suryawanshi A, Rouse BT (2011) An anti-inflammatory role of VEGFR2\/Src kinase inhibitor in herpes simplex virus 1-induced immunopathology. J Virol 85:5995\u20136007. https:\/\/doi.org\/10.1128\/JVI.00034-11","journal-title":"J Virol"},{"key":"2938_CR95","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1172\/JCI13799","volume":"108","author":"D Shukla","year":"2001","unstructured":"Shukla D, Spear PG (2001) Herpesviruses and heparan sulfate: an intimate relationship in aid of viral entry. J Clin Invest 108:503\u2013510. https:\/\/doi.org\/10.1172\/JCI13799","journal-title":"J Clin Invest"},{"issue":"Suppl 1","key":"2938_CR96","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1086\/343739","volume":"186","author":"JS Smith","year":"2002","unstructured":"Smith JS, Robinson NJ (2002) Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review. J Infect Dis 186(Suppl 1):3","journal-title":"J Infect Dis"},{"key":"2938_CR97","doi-asserted-by":"publisher","first-page":"17339","DOI":"10.1073\/pnas.1010026107","volume":"107","author":"MR St Vincent","year":"2010","unstructured":"St Vincent MR, Colpitts CC, Ustinov AV, Muqadas M, Joyce MA, Barsby NL, Epand RF, Epand RM, Khramyshev SA, Valueva OA, Korshun VA, Tyrrell DL, Schang LM (2010) Rigid amphipathic fusion inhibitors, small molecule antiviral compounds against enveloped viruses. Proc Natl Acad Sci USA 107:17339\u201317344. https:\/\/doi.org\/10.1073\/pnas.1010026107","journal-title":"Proc Natl Acad Sci USA"},{"key":"2938_CR98","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1172\/JCI119173","volume":"99","author":"PM Stuart","year":"1997","unstructured":"Stuart PM, Griffith TS, Usui N, Pepose J, Yu X, Ferguson TA (1997) CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival. J Clin Invest 99:396\u2013402","journal-title":"J Clin Invest"},{"key":"2938_CR99","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1167\/iovs.02-0299","volume":"44","author":"PM Stuart","year":"2003","unstructured":"Stuart PM, Pan F, Plambeck S, Ferguson TA (2003) FasL-Fas interactions regulate neovascularization in the cornea. Invest Ophthalmol Vis Sci 44:93\u201398","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2938_CR100","first-page":"372","volume":"42","author":"TH Stumpf","year":"2001","unstructured":"Stumpf TH, Shimeld C, Easty DL, Hill TJ (2001) Cytokine production in a murine model of recurrent herpetic stromal keratitis. Invest Ophthalmol Vis Sci 42:372\u2013378","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2938_CR101","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1099\/0022-1317-83-7-1579","volume":"83","author":"TH Stumpf","year":"2002","unstructured":"Stumpf TH, Case R, Shimeld C, Easty DL, Hill TJ (2002) Primary herpes simplex virus type 1 infection of the eye triggers similar immune responses in the cornea and the skin of the eyelids. J Gen Virol 83:1579\u20131590. https:\/\/doi.org\/10.1099\/0022-1317-83-7-1579","journal-title":"J Gen Virol"},{"key":"2938_CR102","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/aps.2016.160","volume":"38","author":"AR Su","year":"2017","unstructured":"Su AR, Qiu M, Li YL, Xu WT, Song SW, Wang XH, Song HY, Zheng N, Wu ZW (2017) BX-795 inhibits HSV-1 and HSV-2 replication by blocking the JNK\/p38 pathways without interfering with PDK1 activity in host cells. Acta Pharmacol Sin 38:402\u2013414. https:\/\/doi.org\/10.1038\/aps.2016.160","journal-title":"Acta Pharmacol Sin"},{"key":"2938_CR103","doi-asserted-by":"publisher","first-page":"3653","DOI":"10.4049\/jimmunol.1003239","volume":"186","author":"A Suryawanshi","year":"2011","unstructured":"Suryawanshi A, Mulik S, Sharma S, Reddy PBJ, Sehrawat S, Rouse BT (2011) Ocular neovascularization caused by herpes simplex virus type 1 infection results from breakdown of binding between vascular endothelial growth factor A and its soluble receptor. J Immunol 186:3653\u20133665. https:\/\/doi.org\/10.4049\/jimmunol.1003239","journal-title":"J Immunol"},{"key":"2938_CR104","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.smim.2003.10.003","volume":"16","author":"K Takeda","year":"2004","unstructured":"Takeda K, Akira S (2004) TLR signaling pathways. Semin Immunol 16:3\u20139. https:\/\/doi.org\/10.1016\/j.smim.2003.10.003","journal-title":"Semin Immunol"},{"key":"2938_CR105","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.cell.2010.01.045","volume":"140","author":"T Tammela","year":"2010","unstructured":"Tammela T, Alitalo K (2010) Lymphangiogenesis: molecular mechanisms and future promise. Cell 140:460\u2013476. https:\/\/doi.org\/10.1016\/j.cell.2010.01.045","journal-title":"Cell"},{"key":"2938_CR106","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-014-0026-4","author":"D Tang","year":"2014","unstructured":"Tang D, Piao Y, Zhao S, Mu X, Li S, Ma W, Song Y, Wang J, Zhao W, Zhang Q (2014) Expression and correlation of matrix metalloproteinase-9 and heparanase in patients with breast cancer. Med Oncol. https:\/\/doi.org\/10.1007\/s12032-014-0026-4","journal-title":"Med Oncol"},{"key":"2938_CR107","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.4049\/jimmunol.158.3.1383","volume":"158","author":"J Thomas","year":"1997","unstructured":"Thomas J, Gangappa S, Kanangat S, Rouse BT (1997) On the essential involvement of neutrophils in the immunopathologic disease: herpetic stromal keratitis. J Immunol 158:1383\u20131391","journal-title":"J Immunol"},{"key":"2938_CR108","doi-asserted-by":"publisher","first-page":"8970","DOI":"10.1128\/JVI.00296-06","volume":"80","author":"V Tiwari","year":"2006","unstructured":"Tiwari V, Clement C, Xu D, Valyi-Nagy T, Yue BY, Liu J, Shukla D (2006) Role for 3-O-sulfated heparan sulfate as the receptor for herpes simplex virus type 1 entry into primary human corneal fibroblasts. J Virol 80:8970\u20138980","journal-title":"J Virol"},{"key":"2938_CR109","doi-asserted-by":"publisher","first-page":"25406","DOI":"10.1074\/jbc.M110.201103","volume":"286","author":"V Tiwari","year":"2011","unstructured":"Tiwari V, Liu J, Valyi-Nagy T, Shukla D (2011) Anti-heparan sulfate peptides that block herpes simplex virus infection in vivo. J Biol Chem 286:25406\u201325415. https:\/\/doi.org\/10.1074\/jbc.M110.201103","journal-title":"J Biol Chem"},{"key":"2938_CR110","doi-asserted-by":"publisher","first-page":"5272","DOI":"10.1111\/j.1742-4658.2008.06655.x","volume":"275","author":"V Tiwari","year":"2008","unstructured":"Tiwari V, Oh MJ, Kovacs M, Shukla SY, Valyi-Nagy T, Shukla D (2008) Role for nectin-1 in herpes simplex virus 1 entry and spread in human retinal pigment epithelial cells. FEBS J 275:5272\u20135285. https:\/\/doi.org\/10.1111\/j.1742-4658.2008.06655.x","journal-title":"FEBS J"},{"key":"2938_CR111","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1080\/08820530802111085","volume":"23","author":"HS Toma","year":"2008","unstructured":"Toma HS, Murina AT, Areaux RG Jr, Neumann DM, Bhattacharjee PS, Foster TP, Kaufman HE, Hill JM (2008) Ocular HSV-1 latency, reactivation and recurrent disease. Semin Ophthalmol 23:249\u2013273. https:\/\/doi.org\/10.1080\/08820530802111085","journal-title":"Semin Ophthalmol"},{"key":"2938_CR112","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1111\/ceo.12785","volume":"44","author":"M Tsatsos","year":"2016","unstructured":"Tsatsos M, MacGregor C, Athanasiadis I, Moschos MM, Hossain P, Anderson D (2016) Herpes simplex virus keratitis: an update of the pathogenesis and current treatment with oral and topical antiviral agents. Clin Exp Ophthalmol 44:824\u2013837. https:\/\/doi.org\/10.1111\/ceo.12785","journal-title":"Clin Exp Ophthalmol"},{"key":"2938_CR113","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1093\/infdis\/jit350","volume":"208","author":"M van Velzen","year":"2013","unstructured":"van Velzen M, van de Vijver DA, van Loenen FB, Osterhaus AD, Remeijer L, Verjans GM (2013) Acyclovir prophylaxis predisposes to antiviral-resistant recurrent herpetic keratitis. J Infect Dis 208:1359\u20131365. https:\/\/doi.org\/10.1093\/infdis\/jit350","journal-title":"J Infect Dis"},{"key":"2938_CR114","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1093\/clinids\/20.2.414","volume":"20","author":"RJ Whitley","year":"1995","unstructured":"Whitley RJ, Lakeman F (1995) Herpes simplex virus infections of the central nervous system: therapeutic and diagnostic considerations. Clin Infect Dis 20:414\u2013420. https:\/\/doi.org\/10.1093\/clinids\/20.2.414","journal-title":"Clin Infect Dis"},{"key":"2938_CR115","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002278","author":"T Wuest","year":"2011","unstructured":"Wuest T, Zheng M, Efstathiou S, Halford WP, Carr DJJ (2011) The herpes simplex virus-1 transactivator infected cell protein-4 drives VEGF-A dependent Neovascularization. PLoS Pathog. https:\/\/doi.org\/10.1371\/journal.ppat.1002278","journal-title":"PLoS Pathog"},{"key":"2938_CR116","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.omtn.2017.10.009","volume":"9","author":"T Yadavalli","year":"2017","unstructured":"Yadavalli T, Agelidis A, Jaishankar D, Mangano K, Thakkar N, Penmetcha K, Shukla D (2017) Targeting herpes simplex virus-1 gD by a DNA aptamer can be an effective new strategy to curb viral infection. Mol Ther Nucleic Acids 9:365\u2013378. https:\/\/doi.org\/10.1016\/j.omtn.2017.10.009","journal-title":"Mol Ther Nucleic Acids"},{"key":"2938_CR117","doi-asserted-by":"publisher","first-page":"5147","DOI":"10.1128\/JVI.78.10.5147-5156.2004","volume":"78","author":"B Yasin","year":"2004","unstructured":"Yasin B, Wang W, Pang M, Cheshenko N, Hong T, Waring AJ, Herold BC, Wagar EA, Lehrer RI (2004) Theta defensins protect cells from infection by herpes simplex virus by inhibiting viral adhesion and entry. J Virol 78:5147\u20135156","journal-title":"J Virol"},{"key":"2938_CR118","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s13730-012-0035-0","volume":"2","author":"C Yildiz","year":"2013","unstructured":"Yildiz C, Ozsurekci Y, Gucer S, Cengiz AB, Topaloglu R (2013) Acute kidney injury due to acyclovir. CEN Case Rep 2:38\u201340. https:\/\/doi.org\/10.1007\/s13730-012-0035-0","journal-title":"CEN Case Rep"},{"key":"2938_CR119","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1097\/ICO.0b013e318160602d","volume":"27","author":"KC Yoon","year":"2008","unstructured":"Yoon KC, Heo H, Kang IS, Lee MC, Kim KK, Park SH, Cho KO (2008) Effect of topical cyclosporin A on herpetic stromal keratitis in a mouse model. Cornea 27:454\u2013460. https:\/\/doi.org\/10.1097\/ICO.0b013e318160602d","journal-title":"Cornea"},{"key":"2938_CR120","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1126\/science.1139522","volume":"317","author":"S Zhang","year":"2007","unstructured":"Zhang S, Jouanguy E, Ugolini S, Smahi A, Elain G, Romero P, Segal D, Sancho-Shimizu V, Lorenzo L, Puel A, Picard C, Chapgier A, Plancoulaine S, Titeux M, Cognet C, Von Bernuth H, Ku C, Casrouge A, Zhang X, Barreiro L, Leonard J, Hamilton C, Lebon P, Hron B, Valle L, Quintana-Murci L, Hovnanian A, Rozenberg F, Vivier E, Geissmann F, Tardieu M, Abel L, Casanova J (2007) TLR3 deficiency in patients with herpes simplex encephalitis. Science 317:1522\u20131527. https:\/\/doi.org\/10.1126\/science.1139522","journal-title":"Science"},{"key":"2938_CR121","doi-asserted-by":"publisher","first-page":"9828","DOI":"10.1128\/JVI.75.20.9828-9835.2001","volume":"75","author":"M Zheng","year":"2001","unstructured":"Zheng M, Deshpande S, Lee S, Ferrara N, Rouse BT (2001) Contribution of vascular endothelial growth factor in the neovascularization process during the pathogenesis of herpetic stromal keratitis. J Virol 75:9828\u20139835. https:\/\/doi.org\/10.1128\/JVI.75.20.9828-9835.2001","journal-title":"J Virol"},{"key":"2938_CR122","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/S0002-9440(10)61777-4","volume":"159","author":"M Zheng","year":"2001","unstructured":"Zheng M, Schwarz MA, Lee S, Kumaraguru U, Rouse BT (2001) Control of stromal keratitis by inhibition of neovascularization. Am J Pathol 159:1021\u20131029","journal-title":"Am J Pathol"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00018-018-2938-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-018-2938-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-018-2938-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T01:33:09Z","timestamp":1693963989000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00018-018-2938-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,16]]},"references-count":122,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["2938"],"URL":"https:\/\/doi.org\/10.1007\/s00018-018-2938-1","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,16]]},"assertion":[{"value":"15 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}